VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,020 | -71.7% | 4,271 | -26.0% | 0.00% | -80.0% |
| Q2 2023 | $141,636 | +164593.0% | 5,774 | +56.0% | 0.01% | +66.7% |
| Q1 2023 | $86 | -48.5% | 3,701 | -43.9% | 0.00% | -57.1% |
| Q4 2022 | $167 | -99.9% | 6,593 | -1.6% | 0.01% | +250.0% |
| Q3 2022 | $129,000 | -81.0% | 6,697 | -74.9% | 0.00% | -86.7% |
| Q2 2022 | $680,000 | +50.1% | 26,672 | +51.3% | 0.02% | +275.0% |
| Q1 2022 | $453,000 | -31.8% | 17,624 | +11.1% | 0.00% | -63.6% |
| Q4 2021 | $664,000 | +544.7% | 15,861 | +573.8% | 0.01% | +266.7% |
| Q3 2021 | $103,000 | -49.0% | 2,354 | -45.1% | 0.00% | -40.0% |
| Q2 2021 | $202,000 | +68.3% | 4,285 | +83.2% | 0.01% | +150.0% |
| Q1 2021 | $120,000 | +224.3% | 2,339 | +69.7% | 0.00% | +100.0% |
| Q4 2020 | $37,000 | -97.6% | 1,378 | -96.9% | 0.00% | -94.1% |
| Q3 2020 | $1,546,000 | +923.8% | 45,042 | +1120.3% | 0.02% | +183.3% |
| Q2 2020 | $151,000 | +529.2% | 3,691 | +93.4% | 0.01% | +200.0% |
| Q4 2019 | $24,000 | – | 1,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |